# Kellner Capital, LLC

> Institutional holdings reported to the SEC as of Q4 2023 on Form 13F. CIK 1550188. Source: https://holderbook.com/funds/1550188-kellner-capital-llc/

- Reported value: $55.5M
- Positions: 18
- Weight of the ten largest: 82.9%
- Filed: 2024-02-07

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| HESS CORP | [HES](https://holderbook.com/stocks/HES/) | $11.4M | 78,752 | 20.5% | 1 |
| SPLUNK INC | [SPLK](https://holderbook.com/stocks/SPLK/) | $7.5M | 49,400 | 13.6% | 1 |
| PIONEER NAT RES CO | [PXD](https://holderbook.com/stocks/PXD/) | $6.0M | 26,699 | 10.8% | 1 |
| CAPRI HOLDINGS LIMITED | [CPRI](https://holderbook.com/stocks/CPRI/) | $4.2M | 83,600 | 7.6% | 1 |
| SPIRIT RLTY CAP INC NEW | [SRC](https://holderbook.com/stocks/SRC/) | $3.8M | 86,750 | 6.8% | 1 |
| SP PLUS CORP | [SP](https://holderbook.com/stocks/SP/) | $3.5M | 67,836 | 6.3% | 1 |
| ALTERYX INC | [AYX](https://holderbook.com/stocks/AYX/) | $2.5M | 52,800 | 4.5% | 1 |
| MIRATI THERAPEUTICS INC | [MRTX](https://holderbook.com/stocks/MRTX/) | $2.4M | 41,400 | 4.4% | 1 |
| RPT REALTY | [RPT](https://holderbook.com/stocks/RPT/) | $2.4M | 186,699 | 4.3% | 2 |
| SOVOS BRANDS INC | [SOVO](https://holderbook.com/stocks/SOVO/) | $2.3M | 105,425 | 4.2% | 2 |
| IMMUNOGEN INC | [IMGN](https://holderbook.com/stocks/IMGN/) | $2.1M | 69,200 | 3.7% | 1 |
| ENGAGESMART INC | [ESMT](https://holderbook.com/stocks/ESMT/) | $1.8M | 78,400 | 3.2% | 1 |
| HOLLYSYS AUTOMATION TCHNGY L | [HOLI](https://holderbook.com/stocks/HOLI/) | $1.6M | 60,043 | 2.9% | 1 |
| KARUNA THERAPEUTICS INC | [KRTX](https://holderbook.com/stocks/KRTX/) | $1.3M | 4,100 | 2.3% | 1 |
| CEREVEL THERAPEUTICS HLDNG I | [CERE](https://holderbook.com/stocks/CERE/) | $861.0K | 20,300 | 1.6% | 1 |
| UNITED STATES STL CORP NEW | [X](https://holderbook.com/stocks/X/) | $793.0K | 16,300 | 1.4% | 1 |
| RAYZEBIO INC | [RYZB](https://holderbook.com/stocks/RYZB/) | $758.0K | 12,200 | 1.4% | 1 |
| DASEKE INC | [DSKE](https://holderbook.com/stocks/DSKE/) | $379.0K | 46,759 | 0.7% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2023 | -0.9% | +8.3% | -9.2% | 85% |
| Q3 2022 | -5.1% | -5.3% | +0.2% | 61% |
| Q4 2021 | +7.7% | +10.7% | -3.0% | 63% |
| Q2 2020 | +6.0% | +19.6% | -13.6% | 84% |
| Q1 2020 | -17.7% | -19.9% | +2.2% | 62% |
| Q2 2019 | +9.0% | +3.7% | +5.3% | 102% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q4 2023 | $55.5M | 18 |
| Q3 2023 | $85.0M | 21 |
| Q2 2023 | $87.0M | 26 |
| Q1 2023 | $71.7M | 29 |
| Q4 2022 | $85.7M | 33 |
| Q3 2022 | $176.7M | 41 |
| Q2 2022 | $148.3M | 33 |
| Q1 2022 | $134.4M | 31 |
| Q4 2021 | $218.5M | 28 |
| Q3 2021 | $257.1M | 27 |
| Q2 2021 | $326.0M | 31 |
| Q1 2021 | $275.6M | 33 |